LakeShore Biopharma Co Operating Income

LakeShore Biopharma Co (LSB) currently reports a operating income of $-200M as of March 2024. That compares with $-8.2M in the prior-year period — down 2318.9% year over year. Use the charts on this page to explore LakeShore Biopharma Co's operating income history and peer comparisons.

LakeShore Biopharma Co's operating income decreased from $-8.2M to $-200M — a 2318.9% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LakeShore Biopharma Co reported $-200M in operating income as of March 2024. That compares with $-8.2M in the prior-year period — down 2318.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-200M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LakeShore Biopharma Co, and consider following LSB for alerts when major investors trade the stock.